Coronado Biosciences Receives $25,784,568 New Funding

  • Feed Type
  • Date
    7/6/2011
  • Company Name
    Coronado Biosciences
  • Mailing Address
    45 Rockefeller Plaza New York, NY 10111
  • Company Description
    Coronado Biosciences is a clinical stage biopharmaceutical company focused on making cancer care better. How do we define better? We hope to make cancer care safer and more easily tolerated with improved outcomes.
  • Website
    http://www.CoronadoBioSciences.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $25,784,568
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. Amount may include options, warrants or other rights to acquire other securities. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.